Mechanism of action of IL-1 inhibitors - UpToDate
KINERET® (anakinra) Official HCP Website | About
Current mechanisms of IL-1-targeted therapy. Anakinra, a recombinant... | Download Scientific Diagram
Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, Inhibits Apoptosis in Experimental Acute Myocardial Infarction | Circulation
Anakinra: Uses, Interactions, Mechanism of Action | DrugBank Online
Rheumatoid_Arthritis_Treatments_with_Biologics
Frontiers | Controlling Cytokine Storm Is Vital in COVID-19 | Immunology
Current immunotherapy in rheumatoid arthritis | Immunotherapy
Anakinra in familial Mediterranean fever: a profile of its use | SpringerLink
Main pathogenetic pathways of IL-1 production and schematic... | Download Scientific Diagram
Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis. - Abstract - Europe PMC
Interleukin‐1 antagonism in acute gout: Is targeting a single cytokine the answer? - Neogi - 2010 - Arthritis & Rheumatism - Wiley Online Library
![Supplemental Materials for ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5710422a-7b47-4eeb-ac52-48a5a375394e/gr1_lrg.jpg "Supplemental Materials for ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents")
Supplemental Materials for ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents
JCI - Anakinra restores cellular proteostasis by coupling mitochondrial redox balance to autophagy
Mechanisms of actions of anakinra, canakinumab, gevokizumab,... | Download Scientific Diagram
Anakinra - an overview | Semantic Scholar
Interleukin-1β is a potential therapeutic target for periodontitis: a narrative review | International Journal of Oral Science
Strategies for IL-1 blockade with Anakinra and Canakinumab. (A)... | Download Scientific Diagram
Pharmacological mechanism of immunomodulatory agents for the treatment of severe cases of COVID-19 infection | SpringerLink
IJMS | Free Full-Text | Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy | HTML
Novel Pharmacotherapies for Recurrent Pericarditis: Current Options in 2020 | SpringerLink
Figure 2 from Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences | Semantic Scholar
![IL (Interleukin)-1 Receptor Antagonist Increases Ang (Angiotensin [1–7]) and Decreases Blood Pressure in Obese Individuals | Hypertension](https://www.ahajournals.org/cms/asset/c514bc66-af77-4759-b7f9-1503e4f6084b/hypertensionaha.119.13982.fig04.jpg "IL (Interleukin)-1 Receptor Antagonist Increases Ang (Angiotensin [1–7]) and Decreases Blood Pressure in Obese Individuals | Hypertension")
IL (Interleukin)-1 Receptor Antagonist Increases Ang (Angiotensin [1–7]) and Decreases Blood Pressure in Obese Individuals | Hypertension
A potential mode of action for Anakinra in patients with arthrofibrosis following total knee arthroplasty | Scientific Reports
Anakinra Drugbank ID : DB ppt download
Current mechanisms of IL-1-targeted therapy. Anakinra, a recombinant... | Download Scientific Diagram
Mode of action of IL-1 and its inhibitors. (A) The IL-1 inhibitors... | Download Scientific Diagram
Potential roles of IL-1 subfamily members in glycolysis in disease - ScienceDirect
